 | HS4 | 表記: | N-oxidanyl-2-[(4-phenylphenyl)sulfonylamino]ethanamide | 組成式: | C14 H14 N2 O4 S | SMILES: | O=NC(=O)CNS(=O)(=O)c2ccc(c1ccccc1)cc2 | InChi: | InChI=1S/C14H14N2O4S/c17-14(16-18)10-15-21(19,20)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,15,18H,10H2,(H,16,17) | 定義日: | 2008-11-04 | 最終更新日: | 2020-01-07 | 識別子(ID): | N~2~-(biphenyl-4-ylsulfonyl)-N-oxoglycinamide |
|
 | FXH | 表記: | 1-[(dimethylamino)methyl]naphthalen-2-ol | 組成式: | C13 H15 N O | SMILES: | CN(C)Cc1c(O)ccc2ccccc12 | InChi: | InChI=1S/C13H15NO/c1-14(2)9-12-11-6-4-3-5-10(11)7-8-13(12)15/h3-8,15H,9H2,1-2H3 | 定義日: | 2018-08-13 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | 1-[(dimethylamino)methyl]naphthalen-2-ol |
|
 | SFH | 表記: | 5'-O-[(pyridine-3-carbonyl)sulfamoyl]adenosine | 組成式: | C16 H17 N7 O7 S | SMILES: | C3(n1c2c(nc1)c(N)ncn2)OC(C(C3O)O)COS(NC(c4cnccc4)=O)(=O)=O | InChi: | InChI=1S/C16H17N7O7S/c17-13-10-14(20-6-19-13)23(7-21-10)16-12(25)11(24)9(30-16)5-29-31(27,28)22-15(26)8-2-1-3-18-4-8/h1-4,6-7,9,11-12,16,24-25H,5H2,(H,22,26)(H2,17,19,20)/t9-,11-,12-,16-/m1/s1 | 定義日: | 2019-10-09 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | 5'-O-[(pyridine-3-carbonyl)sulfamoyl]adenosine |
|
 | N2V | 表記: | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine | 組成式: | C50 H47 Cl2 N3 O6 | SMILES: | c2(ccc(OCc1cc(Cl)c(cc1)Cl)cc2)C7Oc6cc5CN(C(C(=O)NC(C(=O)O)Cc4ccc(c3c(c(C)ncc3)C)cc4)Cc5cc6OC7)C(c8ccccc8)CC | InChi: | InChI=1S/C50H47Cl2N3O6/c1-4-44(35-8-6-5-7-9-35)55-27-38-26-47-46(60-29-48(61-47)36-15-17-39(18-16-36)59-28-33-12-19-41(51)42(52)22-33)25-37(38)24-45(55)49(56)54-43(50(57)58)23-32-10-13-34(14-11-32)40-20-21-53-31(3)30(40)2/h5-22,25-26,43-45,48H,4,23-24,27-29H2,1-3H3,(H,54,56)(H,57,58)/t43-,44-,45-,48+/m0/s1 | 定義日: | 2019-05-01 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine |
|
 | KJH | 表記: | 1-methylidenenaphthalen-2-one | 組成式: | C11 H8 O | SMILES: | C=C1C(=O)C=Cc2ccccc12 | InChi: | InChI=1S/C11H8O/c1-8-10-5-3-2-4-9(10)6-7-11(8)12/h2-7H,1H2 | 定義日: | 2019-05-24 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | 1-methylidenenaphthalen-2-one |
|
 | LMY | 表記: | ~{N}-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-[2,2,2-tris(fluoranyl)ethyl]thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]methyl]-1-bicyclo[1.1.1]pentanyl]methanamide | 組成式: | C32 H35 F3 N8 O S | SMILES: | CNc1nc(NC2CCN(CC2)Cc3ccc4n(CC56CC(C5)(C6)NC=O)c(cc4c3C)C#N)c7cc(CC(F)(F)F)sc7n1 | InChi: | InChI=1S/C32H35F3N8OS/c1-19-20(3-4-26-24(19)9-22(12-36)43(26)17-30-14-31(15-30,16-30)38-18-44)13-42-7-5-21(6-8-42)39-27-25-10-23(11-32(33,34)35)45-28(25)41-29(37-2)40-27/h3-4,9-10,18,21H,5-8,11,13-17H2,1-2H3,(H,38,44)(H2,37,39,40,41)/t30-,31+ | 定義日: | 2019-03-04 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | ~{N}-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-[2,2,2-tris(fluoranyl)ethyl]thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]methyl]-1-bicyclo[1.1.1]pentanyl]methanamide |
|
 | EGE | 表記: | 4-azanyl-2-oxidanyl-5-[(~{E})-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid | 組成式: | C18 H15 N5 O5 S | SMILES: | Nc1cc(O)c(cc1N=Nc2ccc(cc2)[S](=O)(=O)Nc3ccccn3)C(O)=O | InChi: | InChI=1S/C18H15N5O5S/c19-14-10-16(24)13(18(25)26)9-15(14)22-21-11-4-6-12(7-5-11)29(27,28)23-17-3-1-2-8-20-17/h1-10,24H,19H2,(H,20,23)(H,25,26)/b22-21+ | 定義日: | 2018-03-18 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | 4-azanyl-2-oxidanyl-5-[(~{E})-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid |
|
 | EGH | 表記: | (4~{R})-4-(5-bromanyl-2-fluoranyl-phenyl)-5,6,7-trimethoxy-3,4-dihydro-1~{H}-quinolin-2-one | 組成式: | C18 H17 Br F N O4 | SMILES: | COc1cc2NC(=O)C[CH](c3cc(Br)ccc3F)c2c(OC)c1OC | InChi: | InChI=1S/C18H17BrFNO4/c1-23-14-8-13-16(18(25-3)17(14)24-2)11(7-15(22)21-13)10-6-9(19)4-5-12(10)20/h4-6,8,11H,7H2,1-3H3,(H,21,22)/t11-/m0/s1 | 定義日: | 2018-03-18 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | (4~{R})-4-(5-bromanyl-2-fluoranyl-phenyl)-5,6,7-trimethoxy-3,4-dihydro-1~{H}-quinolin-2-one |
|
 | EGN | 表記: | 4-[2-(4-cyclohexylpiperazin-4-ium-1-yl)-2-oxidanylidene-ethyl]sulfanyl-1-ethyl-quinolin-2-one | 組成式: | C23 H32 N3 O2 S | SMILES: | CCN1C(=O)C=C(SCC(=O)N2CC[NH+](CC2)C3CCCCC3)c4ccccc14 | InChi: | InChI=1S/C23H31N3O2S/c1-2-26-20-11-7-6-10-19(20)21(16-22(26)27)29-17-23(28)25-14-12-24(13-15-25)18-8-4-3-5-9-18/h6-7,10-11,16,18H,2-5,8-9,12-15,17H2,1H3/p+1 | 定義日: | 2018-03-19 | 最終更新日: | 2020-01-03 | 公開日: | 2020-01-08 | 識別子(ID): | 4-[2-(4-cyclohexylpiperazin-4-ium-1-yl)-2-oxidanylidene-ethyl]sulfanyl-1-ethyl-quinolin-2-one |
|
 | NQ2 | 表記: | ~{N}-[2-methoxy-5-[7-[2-[4-(2-oxidanylpropan-2-yl)piperidin-1-yl]ethoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]methanesulfonamide | 組成式: | C25 H35 N3 O6 S | SMILES: | COc1ncc(cc1N[S](C)(=O)=O)c2cc3COCc3c(OCCN4CCC(CC4)C(C)(C)O)c2 | InChi: | InChI=1S/C25H35N3O6S/c1-25(2,29)20-5-7-28(8-6-20)9-10-34-23-13-17(11-19-15-33-16-21(19)23)18-12-22(27-35(4,30)31)24(32-3)26-14-18/h11-14,20,27,29H,5-10,15-16H2,1-4H3 | 定義日: | 2019-12-10 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | ~{N}-[2-methoxy-5-[7-[2-[4-(2-oxidanylpropan-2-yl)piperidin-1-yl]ethoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]methanesulfonamide |
|
 | NQ5 | 表記: | 2-methoxy-~{N}-[2-methoxy-5-[7-[[(2~{R})-4-(oxetan-3-yl)morpholin-2-yl]methoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]ethanesulfonamide | 組成式: | C25 H33 N3 O8 S | SMILES: | COCC[S](=O)(=O)Nc1cc(cnc1OC)c2cc3COCc3c(OC[CH]4CN(CCO4)C5COC5)c2 | InChi: | InChI=1S/C25H33N3O8S/c1-31-5-6-37(29,30)27-23-8-18(10-26-25(23)32-2)17-7-19-12-33-16-22(19)24(9-17)36-15-21-11-28(3-4-35-21)20-13-34-14-20/h7-10,20-21,27H,3-6,11-16H2,1-2H3/t21-/m1/s1 | 定義日: | 2019-12-11 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 2-methoxy-~{N}-[2-methoxy-5-[7-[[(2~{R})-4-(oxetan-3-yl)morpholin-2-yl]methoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]ethanesulfonamide |
|
 | NRZ | 表記: | (2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide | 組成式: | C20 H24 N2 O4 S | SMILES: | COc1ccc(cc1)[S](=O)(=O)N2CCC[CH]2C(=O)Nc3cc(C)cc(C)c3 | InChi: | InChI=1S/C20H24N2O4S/c1-14-11-15(2)13-16(12-14)21-20(23)19-5-4-10-22(19)27(24,25)18-8-6-17(26-3)7-9-18/h6-9,11-13,19H,4-5,10H2,1-3H3,(H,21,23)/t19-/m0/s1 | 定義日: | 2019-12-12 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | (2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide |
|
 | NS2 | 表記: | [(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-methoxy-2-(1,2,3-triazol-2-yl)phenyl]methanone | 組成式: | C23 H23 Cl N6 O2 | SMILES: | COc1ccc(n2nccn2)c(c1)C(=O)N3CCC[C]3(C)c4[nH]c5c(C)c(Cl)ccc5n4 | InChi: | InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 | 定義日: | 2019-12-12 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | [(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-methoxy-2-(1,2,3-triazol-2-yl)phenyl]methanone |
|
 | NT5 | 表記: | [(2~{R},5~{R})-5-[(5-fluoranylpyridin-2-yl)oxymethyl]-2-methyl-piperidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)methanone | 組成式: | C24 H25 F N4 O2 | SMILES: | C[CH]1CC[CH](COc2ccc(F)cn2)CN1C(=O)c3cc(C)ccc3c4ncccn4 | InChi: | InChI=1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1 | 定義日: | 2019-12-12 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | [(2~{R},5~{R})-5-[(5-fluoranylpyridin-2-yl)oxymethyl]-2-methyl-piperidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)methanone |
|
 | NU8 | 表記: | 2-(5,6-dimethoxypyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one | 組成式: | C20 H15 F3 N4 O5 S | SMILES: | COc1cc(cnc1OC)N2C(=O)N(Cc3c(F)cc(F)cc3F)c4ncccc4[S]2(=O)=O | InChi: | InChI=1S/C20H15F3N4O5S/c1-31-16-8-12(9-25-19(16)32-2)27-20(28)26(10-13-14(22)6-11(21)7-15(13)23)18-17(33(27,29)30)4-3-5-24-18/h3-9H,10H2,1-2H3 | 定義日: | 2019-12-13 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 2-(5,6-dimethoxypyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one |
|
 | NV8 | 表記: | 2-[1-(phenylsulfonyl)-1,8-diazaspiro[4.5]decan-8-yl]-1,3-benzoxazole | 組成式: | C21 H23 N3 O3 S | SMILES: | O=[S](=O)(N1CCCC12CCN(CC2)c3oc4ccccc4n3)c5ccccc5 | InChi: | InChI=1S/C21H23N3O3S/c25-28(26,17-7-2-1-3-8-17)24-14-6-11-21(24)12-15-23(16-13-21)20-22-18-9-4-5-10-19(18)27-20/h1-5,7-10H,6,11-16H2 | 定義日: | 2019-12-16 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 2-[1-(phenylsulfonyl)-1,8-diazaspiro[4.5]decan-8-yl]-1,3-benzoxazole |
|
 | NVH | 表記: | 2-(5-methylsulfonylpyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one | 組成式: | C19 H13 F3 N4 O5 S2 | SMILES: | C[S](=O)(=O)c1cncc(c1)N2C(=O)N(Cc3c(F)cc(F)cc3F)c4ncccc4[S]2(=O)=O | InChi: | InChI=1S/C19H13F3N4O5S2/c1-32(28,29)13-7-12(8-23-9-13)26-19(27)25(10-14-15(21)5-11(20)6-16(14)22)18-17(33(26,30)31)3-2-4-24-18/h2-9H,10H2,1H3 | 定義日: | 2019-12-16 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 2-(5-methylsulfonylpyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one |
|
 | NVK | 表記: | 1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea | 組成式: | C17 H13 N5 O2 | SMILES: | Cc1oc2cc(NC(=O)Nc3ccnc4cccnc34)ccc2n1 | InChi: | InChI=1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23) | 定義日: | 2019-12-16 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea |
|
 | NVN | 表記: | 1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4-(dimethylamino)phenyl]urea | 組成式: | C19 H18 F2 N4 O | SMILES: | CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1 | InChi: | InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26) | 定義日: | 2019-12-16 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4-(dimethylamino)phenyl]urea |
|
 | FTW | 表記: | 5-[(4-methoxynaphthalen-1-yl)methyl]-1-[2-[(2-methyl-1-oxidanyl-propan-2-yl)amino]ethyl]-~{N}-(naphthalen-1-ylmethyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridine-3-carboxamide | 組成式: | C36 H41 N5 O3 | SMILES: | COc1ccc(CN2CCc3n(CCNC(C)(C)CO)nc(C(=O)NCc4cccc5ccccc45)c3C2)c6ccccc16 | InChi: | InChI=1S/C36H41N5O3/c1-36(2,24-42)38-18-20-41-32-17-19-40(22-27-15-16-33(44-3)30-14-7-6-13-29(27)30)23-31(32)34(39-41)35(43)37-21-26-11-8-10-25-9-4-5-12-28(25)26/h4-16,38,42H,17-24H2,1-3H3,(H,37,43) | 定義日: | 2018-07-27 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 5-[(4-methoxynaphthalen-1-yl)methyl]-1-[2-[(2-methyl-1-oxidanyl-propan-2-yl)amino]ethyl]-~{N}-(naphthalen-1-ylmethyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridine-3-carboxamide |
|
 | H7S | 表記: | (3S)-3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione | 組成式: | C12 H9 F N2 O2 | SMILES: | C1(C(NC(=O)C1)=O)c2cnc3c2cc(cc3)F | InChi: | InChI=1S/C12H9FN2O2/c13-6-1-2-10-7(3-6)9(5-14-10)8-4-11(16)15-12(8)17/h1-3,5,8,14H,4H2,(H,15,16,17)/t8-/m0/s1 | 定義日: | 2018-06-13 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | (3S)-3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione |
|
 | QJ1 | 表記: | methyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate | 組成式: | C11 H15 N O2 S2 | SMILES: | c1(sccc1)C2CCN(C(OC)=O)CCS2 | InChi: | InChI=1S/C11H15NO2S2/c1-14-11(13)12-5-4-10(16-8-6-12)9-3-2-7-15-9/h2-3,7,10H,4-6,8H2,1H3/t10-/m0/s1 | 定義日: | 2019-11-04 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | methyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate |
|
 | QJA | 表記: | 1-[(7S)-7-(thiophen-2-yl)-6,7-dihydro-1,4-thiazepin-4(5H)-yl]ethan-1-one | 組成式: | C11 H13 N O S2 | SMILES: | CC(N1C=CSC(CC1)c2sccc2)=O | InChi: | InChI=1S/C11H13NOS2/c1-9(13)12-5-4-11(15-8-6-12)10-3-2-7-14-10/h2-3,6-8,11H,4-5H2,1H3/t11-/m0/s1 | 定義日: | 2019-11-04 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 1-[(7S)-7-(thiophen-2-yl)-6,7-dihydro-1,4-thiazepin-4(5H)-yl]ethan-1-one |
|
 | QKD | 表記: | ethyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate | 組成式: | C12 H17 N O2 S2 | SMILES: | C2N(C(OCC)=O)CCC(c1sccc1)SC2 | InChi: | InChI=1S/C12H17NO2S2/c1-2-15-12(14)13-6-5-11(17-9-7-13)10-4-3-8-16-10/h3-4,8,11H,2,5-7,9H2,1H3/t11-/m0/s1 | 定義日: | 2019-11-06 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | ethyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate |
|
 | Q6S | 表記: | N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide | 組成式: | C28 H29 F N4 O3 | SMILES: | N(Cc1cc(cc(c1)OC)OC)C(=O)c3cc(CN2C(/N(C)C=C2)=N)cc(c3)c4ccc(cc4C)F | InChi: | InChI=1S/C28H29FN4O3/c1-18-9-23(29)5-6-26(18)21-10-20(17-33-8-7-32(2)28(33)30)11-22(14-21)27(34)31-16-19-12-24(35-3)15-25(13-19)36-4/h5-15,30H,16-17H2,1-4H3,(H,31,34)/b30-28+ | 定義日: | 2019-09-26 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide |
|